1. Home
  2. ESEA vs NAUT Comparison

ESEA vs NAUT Comparison

Compare ESEA & NAUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Euroseas Ltd. (Marshall Islands)

ESEA

Euroseas Ltd. (Marshall Islands)

HOLD

Current Price

$55.20

Market Cap

432.9M

ML Signal

HOLD

Logo Nautilus Biotechnolgy Inc.

NAUT

Nautilus Biotechnolgy Inc.

HOLD

Current Price

$2.22

Market Cap

245.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESEA
NAUT
Founded
2005
2016
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
432.9M
245.0M
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
ESEA
NAUT
Price
$55.20
$2.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$62.00
N/A
AVG Volume (30 Days)
34.4K
207.9K
Earning Date
02-26-2026
02-26-2026
Dividend Yield
5.13%
N/A
EPS Growth
6.77
N/A
EPS
17.38
N/A
Revenue
$223,794,428.00
N/A
Revenue This Year
$10.05
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.14
N/A
Revenue Growth
7.26
N/A
52 Week Low
$26.30
$0.62
52 Week High
$66.00
$2.54

Technical Indicators

Market Signals
Indicator
ESEA
NAUT
Relative Strength Index (RSI) 44.27 63.16
Support Level $53.00 $1.86
Resistance Level $57.10 $2.05
Average True Range (ATR) 2.33 0.12
MACD 0.02 0.00
Stochastic Oscillator 48.92 100.00

Price Performance

Historical Comparison
ESEA
NAUT

About ESEA Euroseas Ltd. (Marshall Islands)

Euroseas Ltd is a shipping company. Its fleet consists of containerships that transport container boxes, providing scheduled service between ports. Its operations are managed by an affiliated ship management company, which is responsible for the day-to-day commercial and technical management and operations of the vessels. The company employs its vessels on spot and period charters and through pool arrangements.

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Company's products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

Share on Social Networks: